Relapsed/Refractory Diffuse Large B-Cell Lymphoma Clinical Trials in Beijing, Beijing Municipality

Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma